Flu season ends with a whisper, not a bang.

Published Date: 14 Mar 2023

The 2022-2023 flu season is on the edge of life which has been predicted for half of January and most of February.

Read Full News

Latest News

Why Order a CT for Patients With COPD

Imaging helps pinpoint etiotypes, identify COPD phenotypes, and inform treatment.

Paxlovid Still Tops Treatment List for High-Risk COVID Cases

Dr Lum discusses COVID-19 management in the outpatient setting, where Paxlovid is still the first-line treatment for high-risk adults.

The Special Antidepressant That Treats Long COVID

Endometriosis Hormonal Treatments Compromise Bone Health

Hormonal suppression for endometriosis results in a reduction in bone mineral density after up to a year of treatment, with each therapy showing distinct effects, according to a meta-analysis.

DBT Detects Early Cancers With Unchanged Interval Rates

Digital breast tomosynthesis combined with digital mammography detects more early-stage breast cancers, but the incidence shows no reduction in the interval before a follow-up round.

Alcohol Use Disorder Meds May Reduce Hospital Use and Costs

Medications for alcohol use disorder are associated with reduced alcohol-related healthcare utilization and cost savings in real-world settings.

Todays Updates

Skipping Lymph Node Biopsy Gains Ground in Breast Cancer

New data show growing adoption of guidance to skip sentinel lymph node biopsy in older women with early breast cancer, though uptake remains slow and incomplete in the US.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung cancer begs to differ.

Todays Updates

Skipping Lymph Node Biopsy Gains Ground in Breast Cancer

New data show growing adoption of guidance to skip sentinel lymph node biopsy in older women with early breast cancer, though uptake remains slow and incomplete in the US.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung cancer begs to differ.

Latest News

Imaging helps pinpoint etiotypes, identify COPD phenotypes, and inform treatment.

Dr Lum discusses COVID-19 management in the outpatient setting, where Paxlovid is still the first-line treatment for high-risk adults.

Hormonal suppression for endometriosis results in a reduction in bone mineral density after up to a year of treatment, with each therapy showing distinct effects, according to a meta-analysis.

Digital breast tomosynthesis combined with digital mammography detects more early-stage breast cancers, but the incidence shows no reduction in the interval before a follow-up round.

Medications for alcohol use disorder are associated with reduced alcohol-related healthcare utilization and cost savings in real-world settings.

News All Time

Adverse Childhood Experiences Linked to TRD in Adulthood

Exposure to adverse childhood experiences is linked to an increased risk for treatment-resistant depression in adulthood, even after accounting for known risk factors, new data show.

GPs Reject Contract as NHS Reports Record Access

GPs in England have opposed new contract terms in a BMA ballot as NHS England reports a surge in online consultation submissions.

Some Smokers Had Delayed LC Risk, When to Rescreen Debated

A population-based, prospective cohort study conducted in China finds that lung cancer risk remains low until 3 years after a negative low-dose CT screen.

Carboplatin De-Escalation Gains Ground in Early HER2+ BC

New data confirm similar response rates with fewer toxicities when carboplatin is dropped from standard neoadjuvant therapy in early HER2-positive breast cancer.

Anti-Müllerian Hormone and Ovarian Volume Predict PCOS

A model incorporating anti-Müllerian hormone, ovarian volume, hirsutism score, and maximum menstrual cycle length predicts polycystic ovary syndrome.

EMA Recommends Dropping Tecovirimat for Mpox

The decision was based on results of clinical trials suggesting its lack of effectiveness for mpox.

FDA Approves First Gene Therapy for Severe LAD-1

Marne-cel now offers an option to children with the rare immune disorder who lack a sibling donor for stem cell transplantation.

Kidney Risks From COVID Outpace Influenza Impact

COVID is linked to higher risks for subsequent acute kidney injury, chronic kidney disease, and end-stage renal disease than influenza, a new analysis shows.

Cost-Related Nonadherence More Common in Black Canadians

Fewer Black adults than White adults have insurance coverage for prescriptions, according to a new study.

Higher Meat Intake, Lower Dementia Risk — But Only in APOE4

Higher meat intake was linked to lower dementia risk in APOE4 carriers but no other groups, highlighting the potential for genotype-specific dietary guidance.

Hydration Intervention Fails to Prevent Kidney Stones

Although it increased urine volume, a behavioral hydration intervention did not significantly reduce kidney stone recurrence risk.

How to De-escalate Angry or Agitated Patients

De-escalating an angry or agitated patient can be difficult, but it’s important for everyone’s safety and good patient care.

Advanced CKD Symptoms: Women Start Ahead, Men Catch Up Fast

A European cohort of older patients shows that women with advanced CKD report more symptoms than men, but men experience a faster increase in symptom burden over time and as kidney function declines.

Do Isolated Tumor Cells Affect Low-Risk Endometrial Cancer?

A large observational analysis suggests that the presence of isolated tumor cells may signal worse survival in low-risk endometrial cancer.

Comorbid Arthritis and IBD: When Does Each Arise?

The incidence of inflammatory arthritis was highest in the 6 months preceding inflammatory bowel diagnoses for patients younger than 18 years.

Recommended News For You

The pathology of incurable cancers can be predicted thanks to research.

An understudied type of breast cancer poses a lurking threat

Exercise can counter detrimental effects of cancer treatment, review suggests

Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer

Cancer research in the US is world class. With the government pulling out, its future is uncertain

PSA Testing Is Not Enough for Another Candidate for Prostate Cancer Screening.

Mortality up for children with leukemia from lowest SES neighborhoods

Recommended Articles For You

Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment 

Omentum Cancer: Causes, Symptoms, and Treatment Options 

Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research 

A Revolutionary Guide to Calculating Absolute Neutrophil Counts 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.

2.

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

3.

Glioblastoma treatment breakthrough shows promise

4.

Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.

5.

FDA Approves New Drug Combo for RR Multiple Myeloma

1.

A New Hope: How Procarbazine is Revolutionizing Cancer Treatment

2.

The Latest Research on Chronic Granulomatous Disease and Promising New Treatments 

3.

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments

4.

Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options 

5.

Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

2.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

4.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot